Allergan plc Ordinary Shares (AGN) News
Filter AGN News Items
AGN News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest AGN News From Around the Web
Below are the latest news stories about Allergan plc that investors may wish to consider to help them evaluate AGN as an investment opportunity.
Jim Simons' Top Buys of the 1st QuarterFounder of Renaissance Technologies releases portfolio update Continue reading... |
AbbVie Is a Buy as Allergan Deal Closes - A Look at the ChartsAbbVie is rallying now that the company has closed its mega-deal with Allergan. The stock is looking to possibly test 2020 highs. |
Form 8.3 - ALLERGAN PLC - Amendment |
Form 8.3 - Allergan plc |
Form 8.3 - ALLERGAN PLC |
AbbVie Inc. Completes Acquisition of Allergan plcDUBLIN, May 8, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) ("Allergan") announced… |
COVID-19 Impact and Recovery Analysis- Global Chemical Peel Market 2020-2024 | Evolving Opportunities with Allergan Plc and Bausch Health Companies Inc. | TechnavioLONDON--(BUSINESS WIRE)-- #ChemicalPeelMarket--The chemical peel market is poised to grow by 62.78 mn during 2020-2024, according to Technavio |
The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 MillionDUBLIN, May 7, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that The Allergan Foundation has fast-tracked another $2 million dollars in charitable grants for community organizations responding to the COVID-19 pandemic. The new grants double The Allergan Foundation's total… |
AbbVie Scores US Antitrust Approval for $63B Allergan DealAbbVie’s (ABBV) plan to close the $63 billion Allergan (AGN) deal this month appears on track following the announcement that they have received … The post AbbVie Scores US Antitrust Approval for $63B Allergan Deal appeared first on Smarter Analyst . |
Announcement relating to the outcome of the Court Sanction HearingDUBLIN, May 6, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) ("Allergan") today… |